Multidisciplinary Treatment Strategies on OA & NSAIDS
in the 21st Century: Efficacy and Side Effects

Release Date:  March 15, 2011
Expiration Date: March 15, 2013

	How to Obtain AMA PRA Category 1 Credit™ Watch the CME webcast. Take the CME posttest. Login to your account. Complete the registration / evaluation form. Print your personalized CME certificate. Technical Requirements

Estimated Time of Completion:  1 hour

Description

The purpose of this educational activity is to review the most significant scientific and clinical evidence on NSAID use in osteoarthritis and assess its relevance for clinical practice. This studio-produced webcast will present faculty in a moderated panel discussion setting. Topics include: Osteoarthritis: Update on Epidemiology, Therapeutic Goals and Guidelines, Current Evidence on GI Side Effects and NSAIDS Use, and Current Evidence on Cardiovascular Events: Selective and Non-Selective COX Inhibitors. Provided with a knowledgeable approach to management strategies for NSAID use, clinicians will be able to incorporate the latest research findings into their clinical practice and, thus, enhance patient outcomes.

Objectives

At the conclusion of this activity, the participant will be able to do the following:

1. Summarize the most current epidemiologic evidence of OA.
2. Analyze the published efficacy and safety data on NSAIDS and describe their potential impact on clinical practice.
3. Critically appraise safety data on NSAID-related gastrointestinal and cardiovascular effects in patients with OA and discuss preventative strategies.

Target Audience

This activity is intended for rheumatologists, rheumatologist fellows, internists, sports medicine physicians, and other interested health care professionals.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of  1.0 AMA PRA Category 1 Credit™.   Physicians should only claim credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Director

M. Elaine Husni, MD, MPH
Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director, Clinical Outcomes Research
Director, Arthritis and Musculoskeletal Treatment Center
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio

Faculty
 

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentations, could be perceived as a potential conflict of interest:

The following faculty has indicated that she has no relationship which, in the context of her presentation, could be perceived as a potential conflict of interest:

M. Elaine Husni, MD, MPH

All other planners, CME staff, and content reviewers have no relevant financial relationships to disclose.

The Cleveland Clinic Foundation Center for Continuing Education acknowledges
an educational grant for support of this activity from:
AstraZeneca

This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and the Department of Rheumatic and Immunologic Diseases.

CME Disclaimer